As a leader, Novolog views with great importance building a business environment which supports the activities of its partners. Novolog invests resources into:

  • Handling regulatory issues such as intellectual property, health basket negotiation, counterfeiting of drugs and shortening import and releasing processes.
  • Working in close relationship with the Ministry of Health and the central district pharmacist. Novolog supports and smooth regulatory issues and processes
  • Encouraging clinical research to the greatest extent possible which contributes to the deepening of knowledge within Israel’s medical profession.


Enhancing pharmacists' professional knowledge.

The company cultivates and preserves good relations with all organizations connected with health in Israel, such as The Ministry of Health (MoH), national and private health funds, and all pharmaceutical institutions. The company also cooperates closely with The Association of the Research Based Pharmaceutical companies, "Pharma Israel.”